NIBEC Co., Ltd. is a South Korean biotechnology company focused on developing peptide-based therapeutics and tissue regeneration biomaterials. The company has a peptide discovery platform (TOPscovery) with anti-fibrosis therapeutic programs for liver, lung, and heart, as well as a tissue-penetrating peptide carrier platform (NIPEP-TPP). While NIBEC offers a peptide CDMO service, its core business is internal drug development with KFDA-licensed products. The company is primarily a biotech R&D firm, not a standalone CDMO.
peptide therapeutics discovery, anti-fibrosis peptide programs, tissue-penetrating peptide carriers (NIPEP-TPP), tissue regeneration biomaterials, oral healthcare products
1 site worldwide
No reviews available yet.
No documents available.